0001606077-26-000001.txt : 20260126
0001606077-26-000001.hdr.sgml : 20260126
20260126110041
ACCESSION NUMBER: 0001606077-26-000001
CONFORMED SUBMISSION TYPE: D/A
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering
FILED AS OF DATE: 20260126
DATE AS OF CHANGE: 20260126
EFFECTIVENESS DATE: 20260126
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Windgap Medical, Inc.
CENTRAL INDEX KEY: 0001606077
ORGANIZATION NAME:
EIN: 453914066
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-497680
FILM NUMBER: 26558895
BUSINESS ADDRESS:
STREET 1: 200 DEXTER AVENUE
STREET 2: SUITE 270
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: (617) 440-3311
MAIL ADDRESS:
STREET 1: 200 DEXTER AVENUE
STREET 2: SUITE 270
CITY: WATERTOWN
STATE: MA
ZIP: 02472
D/A
1
primary_doc.xml
X0708
D/A
LIVE
0001606077
Windgap Medical, Inc.
200 DEXTER AVENUE
SUITE 270
WATERTOWN
MA
MASSACHUSETTS
02472
(617) 440-3311
DELAWARE
None
None
Corporation
true
Richard
Russell
200 Dexter Avenue
Suite 270
Watertown
MA
MASSACHUSETTS
02472
Director
John
Reading
Wilson
200 Dexter Avenue
Suite 270
Watertown
MA
MASSACHUSETTS
02472
Director
Timothy
Krochuk
200 Dexter Avenue
Suite 270
Watertown
MA
MASSACHUSETTS
02472
Director
Brent
Buchine
200 Dexter Avenue
Suite 270
Watertown
MA
MASSACHUSETTS
02472
Director
Aaron
Mann
200 Dexter Avenue
Suite 270
Watertown
MA
MASSACHUSETTS
02472
Executive Officer
Director
Max
Meehan
200 Dexter Avenue
Suite 270
Watertown
MA
MASSACHUSETTS
02472
Executive Officer
Jason
Durkin
200 Dexter Avenue
Suite 270
Watertown
MA
MASSACHUSETTS
02472
Executive Officer
John
Cadigan
200 Dexter Avenue
Suite 270
Watertown
MA
MASSACHUSETTS
02472
Executive Officer
Anthony
Watson
200 Dexter Avenue
Suite 270
Watertown
MA
MASSACHUSETTS
02472
Executive Officer
Pharmaceuticals
Decline to Disclose
- 06b
true
0001606077-23-000001
2023-11-06
true
true
true
false
0
17250000
12650000
4600000
false
13
0
0
0
false
Windgap Medical, Inc.
/s/ Aaron Mann
Aaron Mann
President and Chief Executive Officer
2026-01-24